The present invention relates to an optical component and others in structure capable of implementing improved compensation for a gain slope. The methods comprise administering a therapeutically effective amount of OX2 alone, or in combination with other therapeutic reagents; or an OX2 antagonist. The bit body includes a bit face. The suspension is subject to a NMR spectroscopy process to produce a sample NMR spectrum.